Clinical trial
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
NCT00127595 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Terminated
Key facts
| NCT number | NCT00127595 |
|---|---|
| Title | Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract |
| Official title | A Phase II Monocentric Study of Oxaliplatin in Combination With Gemcitabine in Patients With Advanced/Metastatic Transitional Cell Carcinoma of the Urothelial Tract |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Transitional Cell |
| Intervention type | Drug |
| Interventions | gemcitabine, oxaliplatin |
| Enrollment | 28 |
| Start date | Jan 1, 2002 |
| Completion | Apr 1, 2005 |
| First posted | Aug 8, 2005 |
| Last update posted | Aug 24, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: